On January 27, 2021 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported that it will present at the Virtual Investor Conference Small and Microcap Showcase on February 4, 2021 (Press release, Genprex, JAN 27, 2021, View Source [SID1234574339]). Genprex’s President and Chief Executive Officer, Rodney Varner, will deliver a virtual company overview, including recent progress made on its upcoming clinical trials.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Virtual Investor Conference

Presentation Date: Thursday, February 4

Presentation Time: 11 a.m. EST

Registration Link: http://bit.ly/396t2bY

The presentation will be available for replay on the Company’s website (www.genprex.com) for a period of time following the conference, and the video will be archived on VirtualInvestorConferences.com.